Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy

Carla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, Stefania Croci, Arianna Palladini, Agnese Antognoli, Annalisa Murgo, Marianna L. Ianzano, Valentina Grosso, Valeria Stivani, Manuela Iezzi, Piero Musiani, Patrizia Nanni, Pier Luigi Lollini

Research output: Contribution to journalArticle

Abstract

The possible interference of tamoxifen with anti-tumor vaccines was studied in a translational view of combined preventive approaches. Tamoxifen treatment of HER-2/neu transgenic mice combined to anti-HER-2/neu cell vaccine did not hamper the efficacy of cancer immunoprevention, and caused a significantly increased production of interferon-γ. These data suggest that tamoxifen could even have a positive impact on the efficacy of cancer immunoprevention.

Original languageEnglish
Pages (from-to)2065-2069
Number of pages5
JournalVaccine
Volume27
Issue number14
DOIs
Publication statusPublished - Mar 23 2009

Fingerprint

tamoxifen
Tamoxifen
Vaccines
vaccines
neoplasms
Neoplasms
Cancer Vaccines
cells
interferons
crossover interference
Interferons
Transgenic Mice
genetically modified organisms
mice

Keywords

  • Breast cancer
  • Tamoxifen
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. / De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Croci, Stefania; Palladini, Arianna; Antognoli, Agnese; Murgo, Annalisa; Ianzano, Marianna L.; Grosso, Valentina; Stivani, Valeria; Iezzi, Manuela; Musiani, Piero; Nanni, Patrizia; Lollini, Pier Luigi.

In: Vaccine, Vol. 27, No. 14, 23.03.2009, p. 2065-2069.

Research output: Contribution to journalArticle

De Giovanni, C, Nicoletti, G, Landuzzi, L, Croci, S, Palladini, A, Antognoli, A, Murgo, A, Ianzano, ML, Grosso, V, Stivani, V, Iezzi, M, Musiani, P, Nanni, P & Lollini, PL 2009, 'Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy', Vaccine, vol. 27, no. 14, pp. 2065-2069. https://doi.org/10.1016/j.vaccine.2009.01.113
De Giovanni, Carla ; Nicoletti, Giordano ; Landuzzi, Lorena ; Croci, Stefania ; Palladini, Arianna ; Antognoli, Agnese ; Murgo, Annalisa ; Ianzano, Marianna L. ; Grosso, Valentina ; Stivani, Valeria ; Iezzi, Manuela ; Musiani, Piero ; Nanni, Patrizia ; Lollini, Pier Luigi. / Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. In: Vaccine. 2009 ; Vol. 27, No. 14. pp. 2065-2069.
@article{0daee4156b104110ad2526627e0a2559,
title = "Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy",
abstract = "The possible interference of tamoxifen with anti-tumor vaccines was studied in a translational view of combined preventive approaches. Tamoxifen treatment of HER-2/neu transgenic mice combined to anti-HER-2/neu cell vaccine did not hamper the efficacy of cancer immunoprevention, and caused a significantly increased production of interferon-γ. These data suggest that tamoxifen could even have a positive impact on the efficacy of cancer immunoprevention.",
keywords = "Breast cancer, Tamoxifen, Vaccine",
author = "{De Giovanni}, Carla and Giordano Nicoletti and Lorena Landuzzi and Stefania Croci and Arianna Palladini and Agnese Antognoli and Annalisa Murgo and Ianzano, {Marianna L.} and Valentina Grosso and Valeria Stivani and Manuela Iezzi and Piero Musiani and Patrizia Nanni and Lollini, {Pier Luigi}",
year = "2009",
month = "3",
day = "23",
doi = "10.1016/j.vaccine.2009.01.113",
language = "English",
volume = "27",
pages = "2065--2069",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "14",

}

TY - JOUR

T1 - Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy

AU - De Giovanni, Carla

AU - Nicoletti, Giordano

AU - Landuzzi, Lorena

AU - Croci, Stefania

AU - Palladini, Arianna

AU - Antognoli, Agnese

AU - Murgo, Annalisa

AU - Ianzano, Marianna L.

AU - Grosso, Valentina

AU - Stivani, Valeria

AU - Iezzi, Manuela

AU - Musiani, Piero

AU - Nanni, Patrizia

AU - Lollini, Pier Luigi

PY - 2009/3/23

Y1 - 2009/3/23

N2 - The possible interference of tamoxifen with anti-tumor vaccines was studied in a translational view of combined preventive approaches. Tamoxifen treatment of HER-2/neu transgenic mice combined to anti-HER-2/neu cell vaccine did not hamper the efficacy of cancer immunoprevention, and caused a significantly increased production of interferon-γ. These data suggest that tamoxifen could even have a positive impact on the efficacy of cancer immunoprevention.

AB - The possible interference of tamoxifen with anti-tumor vaccines was studied in a translational view of combined preventive approaches. Tamoxifen treatment of HER-2/neu transgenic mice combined to anti-HER-2/neu cell vaccine did not hamper the efficacy of cancer immunoprevention, and caused a significantly increased production of interferon-γ. These data suggest that tamoxifen could even have a positive impact on the efficacy of cancer immunoprevention.

KW - Breast cancer

KW - Tamoxifen

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=61549111856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61549111856&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.01.113

DO - 10.1016/j.vaccine.2009.01.113

M3 - Article

C2 - 19428831

AN - SCOPUS:61549111856

VL - 27

SP - 2065

EP - 2069

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 14

ER -